2022-05-30
24th April, 2022 — Exciting good news for NNB and GCVL. The joint efforts of both companies have resulted in NNB's patented MitoPrime® (L-ergothioneine) gaining FSSAI regulatory access for food and supplements. NNB Nutrition (NNB) is a leading technological enterprise dedicated to research, development, production and sales of high-quality, innovative nutritional and functional food ingredients. GCV Life (GCVL) is a first-class healthcare and life science-focused company which works with global innovators and commercializes novel life science solutions in the Asian markets. Getting FSSAI regulatory approval for MitoPrime® (L-ergothioneine) has allowed both paties to see the broad market prospects in India and Southeast Asia, and it has also made both parties more convinced of the huge potential and value of innovative dietary supplements.
Making a nutritional food ingredient company get food and supplement regulatory like GRAS, NHP, and FSSAI is extremely important. NNB is approved by FSSAI. This is a significant achievement for any supplement company, big, medium, or small. The Food Safety and Standards Authority of India (FSSAI), which was established under Food Safety and Standards, strictly regulate their manufacture, storage, distribution, sale and import to ensure availability of safe and wholesome food for human consumption. Not everyone is accepted and approved by FSSAI but NNB made it, which means our ingredients are very safe and reliable. As an innovative ingredients creator, NNB reached its milestone of being available at FSSAI and grow immensely over the years with no sign of slowing down.
It will bring rapid development of both parties in the field of food and health products and help them quickly occupy the market of ergothioneine. NNB is confident in developing the high growth markets of India and South Asia because GCV Life is in the life sciences and healthcare industries and NNB Nutrition constantly designs and delivers innovative ingredients as well as health solutions with high reputation, which will be able to bring commercialized value to the market.
About MitoPrime®
MitoPrime®, NNB's pure Ergothioneine, is NNB Biotech’s bio-perfected form of the histone derivative L-ergothioneine now is backed by over 15 studies including clinical trials, human cell & pharma-model C Elegans. Its anti-oxidation capabilities are stronger than any other product known to mankind. It can eliminate the deadliest radical, singlet oxygen, up to 7,500% Better than any Antioxidant Known Today. In addition, this Ergothioneine can eliminates all oxidants 3,000% better than glutathione and inhibits lipid per-oxidation 270% better than CoQ10. MitoPrime® is a pathbreaking innovation and its claims in dietary supplement field are shown as below:
Besides the claims mentioned above, MitoPrime® is also very effective in skin care and cosmetics application. It can reduce wrinkle depth, increase skin radiance, improve skin smoothness & elasticity, generate new collagen, inhibits inflammation & unfavorable skin bacteria, and prevent cells from becoming zombie cells. For more information, visit https://mitoprimennb.com/
If you’re in a company with strong spirit to lead the dietary supplement, skin care, and cosmetics market, as well as with an appreciation for science-backed ingredients, please get in touch with us and NNB will make huge difference to the world.
About NNB nutrition
NNB is the leading ingredient-driven biotech company employing over 100 research scientists from more than 10 countries who study, design, and deliver unique ingredients to this industry to maximize health, augment performance, expand longevity and enhance appearance. NNB fosters partnerships with companies in the fields of nutraceuticals, pharmaceuticals, and medical research.
About GCV Life
GCV Life is a boutique venture focused on select sectors providing investment banking and innovation licensing services to life science & healthcare companies. Operating for over a decade as an investment bank, GCVL has closed many deals for Mergers & Acquisitions, Fund Raise & Licensing globally. Under Innovation Licensing, GCVL represents over 15 innovators with Intellectual Property-protected products across pharmaceuticals, nutraceuticals & medical devices for commercializing in India & other emerging markets. GCVL has developed a very unique & differentiated business model that has enabled faster commercialization maximizing return on investment for its Innovation partners.
Contact Us
Company： Nanjing Nutrabuilding Bio-tech Co., LTD. (NNB Nutrition）
Contact Person: Amanda
Email:amanda@nnbnutrition.com
Website: https://www.nnbnutrition.com/
Telephone: +86-25 5881 2792
Location：No. 270 Jiqingmen Street, Suning Huigu, Building E6, Room 2105
Nanjing, China 210017